MOLECULAR PARTNERS AG (MOLN) AI Dilution Summary
Updated Oct 6, 2026
Molecular Partners reported cash of $67,930,000 at its 2026-06-30 balance-sheet date, against estimated monthly burn of $3,597,667. Its active funding channel is an at-the-market program with Leerink Partners LLC, authorised to $100,000,000. The main driver is the F-3 shelf registration 333-286488, registered to $300,000,000 with $300,000,000 remaining, which expires 2028-04-24.